You can get tirzepatide online through telehealth platforms that connect you with a licensed prescriber who evaluates your eligibility and sends the prescription to a pharmacy for home delivery. The process typically involves filling out a health questionnaire, completing a video or asynchronous medical consultation, and receiving your medication by mail if you qualify. However, the landscape has shifted significantly in 2025, and understanding what’s legitimate versus risky requires some context.
Two Brand Names, Two Different Indications
Tirzepatide is sold under two brand names, and which one you’re prescribed depends on why you need it. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is FDA-approved for chronic weight management. They contain the same active ingredient at the same doses, but your provider will prescribe one or the other based on your diagnosis. If you’re pursuing tirzepatide specifically for weight loss through a telehealth platform, Zepbound is the version you’d be prescribed.
Who Qualifies for a Prescription
The FDA approval for Zepbound sets clear BMI thresholds. You need either a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease. The prescription is meant to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone fix.
Most telehealth platforms screen for these criteria upfront. You’ll answer questions about your height, weight, medical history, and current medications before a provider reviews your case. Some platforms ask for recent bloodwork (a basic metabolic panel, A1C, or lipid panel), though requirements vary. If you haven’t had labs done in the past year or two, getting baseline numbers is worth doing regardless. It gives you and your provider a reference point to track changes over time, and basic panels can cost as little as $10 to $30 per test through discount lab services.
What the Telehealth Process Looks Like
The typical workflow across most legitimate telehealth platforms follows the same general pattern. You start by completing an online intake form covering your health history, weight loss goals, and any medications you currently take. A licensed provider in your state reviews your information, and some platforms conduct a live video visit while others use asynchronous messaging where the provider follows up with questions before making a decision.
If you’re approved, the prescription goes to a pharmacy that ships the medication to your home. Brand-name tirzepatide (Zepbound) ships as a pre-filled pen that must stay refrigerated between 2°C and 8°C (roughly 36°F to 46°F) until first use. After the first injection, the pen can be stored at room temperature up to 86°F. It should never be frozen, and it needs to be kept out of direct light. If your package arrives warm or without adequate cold packs, don’t use it.
Many platforms also provide ongoing support through a mobile app where you can track progress, message your prescriber, and manage dose adjustments. Tirzepatide follows a gradual dose escalation schedule, starting low and increasing over several months to reduce side effects, so regular check-ins with your provider matter.
The Cost Reality
Brand-name Zepbound carries a high list price, and insurance coverage remains inconsistent. Many commercial plans still exclude weight management medications, which leaves a lot of people paying out of pocket. Eli Lilly, the manufacturer, offers a savings card for self-paying patients that provides up to $100 off per one-month fill, $200 off per two-month fill, or $300 off per three-month fill. The annual cap is $1,300 in savings, and the card is valid through the end of 2026. This helps, but the out-of-pocket cost even with the discount remains substantial for most people.
On top of the medication itself, factor in the telehealth consultation fee, which varies by platform and may be charged monthly or per visit. Some bundle the consultation into a subscription model, others charge separately.
Compounded Tirzepatide: What You Need to Know
The high cost of brand-name tirzepatide drove many people toward compounded versions, which compounding pharmacies could legally produce while tirzepatide was listed on the FDA’s drug shortage list. That shortage has since resolved. As of now, tirzepatide does not appear on the FDA’s drug shortage list or the approved bulks list for outsourcing facilities, which significantly restricts the legal basis for compounding it.
Even when compounded tirzepatide was more widely available, safety concerns were real. The FDA has received 545 adverse event reports associated with compounded tirzepatide as of July 2025. Some compounding pharmacies used salt forms of tirzepatide (like tirzepatide sodium or tirzepatide acetate) that the FDA says have no established basis for use in compounding. The agency has stated it lacks information on whether these salt forms share the same chemical and pharmacologic properties as the active ingredient in the approved drug.
The FDA has also flagged fraudulent products labeled as compounded tirzepatide that contained false information on packaging, as well as reports of compounded versions being prescribed at doses beyond what the approved labeling recommends. Some patients received higher single doses, more frequent dosing, or faster dose escalation than the standard schedule. The resulting adverse events included nausea, vomiting, diarrhea, abdominal pain, and constipation serious enough to require medical attention.
Shipping problems added another layer of risk. The FDA received complaints about compounded injectable GLP-1 drugs arriving warm or with insufficient ice packs, which can degrade the medication’s quality.
How to Verify a Legitimate Online Provider
Whether you’re using a telehealth platform or an online pharmacy, a few non-negotiable markers separate legitimate operations from questionable ones. A safe online pharmacy always requires a valid prescription from a licensed provider. It lists a physical U.S. address and a working phone number. It has a licensed pharmacist available to answer questions. And it holds a license with a state board of pharmacy.
Be skeptical of any site that offers tirzepatide without a medical evaluation, promises guaranteed approval, or ships from outside the United States. Tirzepatide is not a controlled substance, so the strictest federal telehealth rules around in-person visit requirements don’t apply. But a real provider will still conduct a thorough medical evaluation, ask about contraindications (like a personal or family history of certain thyroid cancers), and say no to patients who don’t meet prescribing criteria.
What to Expect After You Start
Tirzepatide is a once-weekly injection you give yourself in the abdomen, thigh, or upper arm. The starting dose is low, and your provider will increase it gradually over several months. This slow ramp-up is intentional. It gives your body time to adjust and reduces the intensity of gastrointestinal side effects, which are the most common reason people struggle early on. Nausea, decreased appetite, diarrhea, and constipation are all typical in the first weeks after a dose increase and usually improve with time.
Your telehealth provider should schedule regular follow-ups to assess your response, adjust your dose, and monitor for any issues. If a platform writes you a prescription and disappears, that’s a red flag. Ongoing medical oversight isn’t optional with this class of medication.